Anthony Petrone

Stock Analyst at Mizuho

(3.72)
# 686
Out of 5,182 analysts
218
Total ratings
49.7%
Success rate
7.67%
Average return

Stocks Rated by Anthony Petrone

MannKind
Apr 13, 2026
Maintains: Outperform
Price Target: $10$8
Current: $2.63
Upside: +204.18%
Medtronic
Apr 13, 2026
Maintains: Outperform
Price Target: $125$120
Current: $82.92
Upside: +44.72%
Lantheus Holdings
Apr 13, 2026
Maintains: Outperform
Price Target: $85$95
Current: $84.11
Upside: +12.95%
Intuitive Surgical
Apr 13, 2026
Maintains: Neutral
Price Target: $575$525
Current: $470.99
Upside: +11.47%
Inspire Medical Systems
Apr 13, 2026
Maintains: Outperform
Price Target: $85$70
Current: $55.07
Upside: +27.11%
Haemonetics
Apr 13, 2026
Maintains: Outperform
Price Target: $80$70
Current: $60.48
Upside: +15.74%
GE HealthCare Technologies
Apr 13, 2026
Maintains: Outperform
Price Target: $95$90
Current: $70.48
Upside: +27.70%
Edwards Lifesciences
Apr 13, 2026
Maintains: Outperform
Price Target: $100$95
Current: $83.46
Upside: +13.83%
Embecta
Apr 13, 2026
Maintains: Neutral
Price Target: $14$12
Current: $9.21
Upside: +30.29%
Boston Scientific
Apr 13, 2026
Maintains: Outperform
Price Target: $115$90
Current: $59.95
Upside: +50.13%
Maintains: Outperform
Price Target: $30$24
Current: $10.93
Upside: +119.58%
Initiates: Outperform
Price Target: $21
Current: $12.92
Upside: +62.54%
Maintains: Outperform
Price Target: $90$100
Current: $65.47
Upside: +52.74%
Maintains: Neutral
Price Target: $21$22
Current: $19.82
Upside: +11.00%
Maintains: Outperform
Price Target: $78$90
Current: $61.41
Upside: +46.56%
Maintains: Outperform
Price Target: $12$10
Current: $3.34
Upside: +199.40%
Maintains: Outperform
Price Target: $70$72
Current: $63.41
Upside: +13.55%
Maintains: Outperform
Price Target: $100$120
Current: $88.50
Upside: +35.59%
Maintains: Outperform
Price Target: $85$100
Current: $64.34
Upside: +55.42%
Initiates: Outperform
Price Target: $40
Current: $39.39
Upside: +1.55%
Maintains: Outperform
Price Target: $110$100
Current: $76.01
Upside: +31.56%
Maintains: Outperform
Price Target: $310$300
Current: $222.02
Upside: +35.12%
Maintains: Neutral
Price Target: $130$135
Current: $135.07
Upside: -0.05%
Maintains: Neutral
Price Target: $140$135
Current: $92.80
Upside: +45.47%
Maintains: Neutral
Price Target: $17$18
Current: $26.68
Upside: -32.53%
Maintains: Outperform
Price Target: $200$175
Current: $122.07
Upside: +43.36%
Initiates: Outperform
Price Target: $40
Current: $7.27
Upside: +450.21%
Maintains: Buy
Price Target: $54$58
Current: $60.93
Upside: -4.81%
Downgrades: Hold
Price Target: $63$67
Current: $114.52
Upside: -41.49%
Maintains: Buy
Price Target: $200$175
Current: $92.59
Upside: +89.01%
Maintains: Hold
Price Target: $30$25
Current: $12.71
Upside: +96.70%